Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ06
- Pharmacological subgroupJ06BImmunoglobulins
- Chemical subgroupJ06BD
- Chemical substanceJ06BD08Nirsevimab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 2 registrations
Spain
AEMPS · 2 registrations
Netherlands
CBG-MEB · 2 registrations
At a glance
- ATC code
- J06BD08
- ATC group
- Anti-infectives for systemic use
- Registers
- 8
- Registrations
- 12
- With their own page
- 12
- Companies
- 7
All medicines with Nirsevimab
Human medicines from every register that match Nirsevimab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
12 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Beyfortus | United States | 100MG, 50MG | injectable | Marketed | Astrazeneca AB |
| Beyfortus | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Beyfortus 100 MG Solucion Inyectable en Jeringa Precargada | Spain | 100 mg | solución inyectable en jeringa precargada | Marketed | Sanofi Winthrop Industrie |
| Beyfortus 50 MG Solucion Inyectable en Jeringa Precargada | Spain | 100 mg | solución inyectable en jeringa precargada | Marketed | Sanofi Winthrop Industrie |
| Beyfortus 100 mg, oplossing voor injectie in een voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Sanofi Winthrop Industrie | |
| Beyfortus 50 mg, oplossing voor injectie in een voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Sanofi Winthrop Industrie | |
| Beyfortus | Canada | 50 MG / 0.5 ML | Solution | Marketed | Sanofi Vaccines Canada LTD. |
| Beyfortus | Canada | 100 MG / 1 ML | Solution | Marketed | Sanofi Vaccines Canada LTD. |
| Beyfortus | Brazil | Authorised | Sanofi Medley Farmacêutica Ltda. | ||
| Beyfortus Solution for Injection in Pre-Filled Syringe 100 MG/ 1.0 ML | Singapore | 100 mg / 1.0 mL | injection, solution | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Beyfortus Solution for Injection in Pre-Filled Syringe 50 MG/ 0.5 ML | Singapore | 50 mg/ 0.5 mL | injection, solution | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Beyfortus | Croatia | Authorised |